CN101014698A - 作为多种疫苗候选物的保守性内核脂多糖表位 - Google Patents

作为多种疫苗候选物的保守性内核脂多糖表位 Download PDF

Info

Publication number
CN101014698A
CN101014698A CNA2005800235097A CN200580023509A CN101014698A CN 101014698 A CN101014698 A CN 101014698A CN A2005800235097 A CNA2005800235097 A CN A2005800235097A CN 200580023509 A CN200580023509 A CN 200580023509A CN 101014698 A CN101014698 A CN 101014698A
Authority
CN
China
Prior art keywords
hep
core
lps
lipopolysaccharide
glc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800235097A
Other languages
English (en)
Chinese (zh)
Inventor
安德鲁·考克斯
詹姆斯·C.·理查兹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Research Council of Canada
Original Assignee
National Research Council of Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Council of Canada filed Critical National Research Council of Canada
Publication of CN101014698A publication Critical patent/CN101014698A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0001—Archaeal antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
CNA2005800235097A 2004-05-14 2005-05-16 作为多种疫苗候选物的保守性内核脂多糖表位 Pending CN101014698A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2,467,329 2004-05-14
CA002467329A CA2467329A1 (en) 2004-05-14 2004-05-14 Inner core lps epitopes and uses thereof
US60/571,489 2004-05-17

Publications (1)

Publication Number Publication Date
CN101014698A true CN101014698A (zh) 2007-08-08

Family

ID=35452161

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800235097A Pending CN101014698A (zh) 2004-05-14 2005-05-16 作为多种疫苗候选物的保守性内核脂多糖表位

Country Status (3)

Country Link
CN (1) CN101014698A (pl)
CA (1) CA2467329A1 (pl)
PL (1) PL381833A1 (pl)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105497885A (zh) * 2014-09-25 2016-04-20 普莱柯生物工程股份有限公司 一种亚单位疫苗及其制备方法和应用
CN109239341A (zh) * 2018-07-04 2019-01-18 西南大学 一种牛溶血性曼氏杆菌抗体检测的间接elisa试剂盒及其应用
CN110072872A (zh) * 2016-11-04 2019-07-30 环境、食品及农村国务部 包含至少7个单元的4,6-二氧-4酰胺基-α-吡喃糖的封闭的低聚糖及其结合物作为预防由布鲁氏菌生物引起的感染的疫苗
CN111850003A (zh) * 2020-07-09 2020-10-30 华中农业大学 一种重组表达的多杀性巴氏杆菌硫胺素周质结合蛋白及应用
CN114450312A (zh) * 2019-09-24 2022-05-06 生物医学研究集团有限公司 脂多糖的制造方法
CN115772506A (zh) * 2022-12-09 2023-03-10 内蒙古自治区农牧业科学院 一种溶血性曼氏杆菌plpe蛋白单克隆抗体及其制备方法和应用

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2326671A4 (en) * 2008-09-05 2012-10-03 Ca Nat Research Council LIPOPOLYOSIDIC VACCINES

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105497885A (zh) * 2014-09-25 2016-04-20 普莱柯生物工程股份有限公司 一种亚单位疫苗及其制备方法和应用
CN105497885B (zh) * 2014-09-25 2019-02-15 普莱柯生物工程股份有限公司 一种亚单位疫苗及其制备方法和应用
CN110072872A (zh) * 2016-11-04 2019-07-30 环境、食品及农村国务部 包含至少7个单元的4,6-二氧-4酰胺基-α-吡喃糖的封闭的低聚糖及其结合物作为预防由布鲁氏菌生物引起的感染的疫苗
CN110072872B (zh) * 2016-11-04 2024-01-16 环境、食品及农村国务部 预防由布鲁氏菌生物引起的感染的疫苗
CN109239341A (zh) * 2018-07-04 2019-01-18 西南大学 一种牛溶血性曼氏杆菌抗体检测的间接elisa试剂盒及其应用
CN109239341B (zh) * 2018-07-04 2021-08-24 西南大学 一种牛溶血性曼氏杆菌抗体检测的间接elisa试剂盒及其应用
CN114450312A (zh) * 2019-09-24 2022-05-06 生物医学研究集团有限公司 脂多糖的制造方法
CN114450312B (zh) * 2019-09-24 2024-02-23 生物医学研究集团有限公司 脂多糖的制造方法
CN111850003A (zh) * 2020-07-09 2020-10-30 华中农业大学 一种重组表达的多杀性巴氏杆菌硫胺素周质结合蛋白及应用
CN115772506A (zh) * 2022-12-09 2023-03-10 内蒙古自治区农牧业科学院 一种溶血性曼氏杆菌plpe蛋白单克隆抗体及其制备方法和应用

Also Published As

Publication number Publication date
PL381833A1 (pl) 2007-07-23
CA2467329A1 (en) 2005-11-14

Similar Documents

Publication Publication Date Title
JP3595264B2 (ja) 遺伝的に修飾されたグラム陰性細菌由来の低毒性ｌｐｓ
JP5501969B2 (ja) クロストリジウム・ディフィシル由来の多糖免疫原
CN106535927A (zh) 新颖多糖及其用途
EP2892566A1 (en) Bioconjugates comprising modified antigens and uses thereof
CN115803087A (zh) 多价疫苗组合物及其用途
US20160136285A1 (en) An isolated immunogenic bacterial antigen and its use in the prevention and treatment of infections caused by gram-negative bacteria
CN101014698A (zh) 作为多种疫苗候选物的保守性内核脂多糖表位
US7759070B2 (en) Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates
US7364739B2 (en) Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of Haemophilus influenzae infections
JP2004506086A5 (pl)
KR20070031936A (ko) 다종 백신 후보로서의 보존된 내부 코어 지질다당류에피토프
US11078257B2 (en) Recombinant gram negative bacteria and methods of generating and utilizing same
KR20240161137A (ko) 녹농균 감염의 예방/치료
Omari Synthesis of Campylobacter and Shigella glycoconjugate Vaccines
Donaldson Antimicrobial Carbohydrate Vaccines: Development of Burkholderia pseudomallei immunogens
HK1189508A (en) Polysaccharide immunogens from clostridium difficile
CA2518317A1 (en) Phosphoramide and uses thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20070808